161 related articles for article (PubMed ID: 34203905)
1. Next Generation Cytogenetics in Myeloid Hematological Neoplasms: Detection of CNVs and Translocations.
Chicano M; Carbonell D; Suárez-González J; Lois S; Ballesteros-Culebras M; Andrés-Zayas C; Muñiz P; Rodríguez-Macias G; Bastos-Oreiro M; Font P; Ballesteros M; Kwon M; Anguita J; Díez-Martín JL; Buño I; Martínez-Laperche C
Cancers (Basel); 2021 Jun; 13(12):. PubMed ID: 34203905
[TBL] [Abstract][Full Text] [Related]
2. Addition of chromosomal microarray and next generation sequencing to FISH and classical cytogenetics enhances genomic profiling of myeloid malignancies.
Mukherjee S; Sathanoori M; Ma Z; Andreatta M; Lennon PA; Wheeler SR; Prescott JL; Coldren C; Casey T; Rietz H; Fasig K; Woodford R; Hartley T; Spence D; Donnelan W; Berdeja J; Flinn I; Kozyr N; Bouzyk M; Correll M; Ho H; Kravtsov V; Tunnel D; Chandra P
Cancer Genet; 2017 Oct; 216-217():128-141. PubMed ID: 29025587
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of copy number variant detection from panel-based next-generation sequencing data.
Yao R; Yu T; Qing Y; Wang J; Shen Y
Mol Genet Genomic Med; 2019 Jan; 7(1):e00513. PubMed ID: 30565893
[TBL] [Abstract][Full Text] [Related]
4. Next-Generation Sequencing Improves Diagnosis, Prognosis and Clinical Management of Myeloid Neoplasms.
Carbonell D; Suárez-González J; Chicano M; Andrés-Zayas C; Triviño JC; Rodríguez-Macías G; Bastos-Oreiro M; Font P; Ballesteros M; Muñiz P; Balsalobre P; Kwon M; Anguita J; Díez-Martín JL; Buño I; Martínez-Laperche C
Cancers (Basel); 2019 Sep; 11(9):. PubMed ID: 31540291
[TBL] [Abstract][Full Text] [Related]
5. Concurrent detection of targeted copy number variants and mutations using a myeloid malignancy next generation sequencing panel allows comprehensive genetic analysis using a single testing strategy.
Shen W; Szankasi P; Sederberg M; Schumacher J; Frizzell KA; Gee EP; Patel JL; South ST; Xu X; Kelley TW
Br J Haematol; 2016 Apr; 173(1):49-58. PubMed ID: 26728869
[TBL] [Abstract][Full Text] [Related]
6. Reliability of Cell-Free DNA and Targeted NGS in Predicting Chromosomal Abnormalities of Patients With Myeloid Neoplasms.
Ip A; Della Pia A; Kim GYG; Lofters J; Behrmann J; Patel D; Kats S; Estella JJ; De Dios I; Ma W; Pecora AL; Goy AH; Koprivnikar J; McCloskey JK; Albitar M
Front Oncol; 2022; 12():923809. PubMed ID: 35774119
[TBL] [Abstract][Full Text] [Related]
7. Accurate clinical detection of exon copy number variants in a targeted NGS panel using DECoN.
Fowler A; Mahamdallie S; Ruark E; Seal S; Ramsay E; Clarke M; Uddin I; Wylie H; Strydom A; Lunter G; Rahman N
Wellcome Open Res; 2016 Nov; 1():20. PubMed ID: 28459104
[No Abstract] [Full Text] [Related]
8. Comprehensive Custom NGS Panel Validation for the Improvement of the Stratification of B-Acute Lymphoblastic Leukemia Patients.
Montaño A; Hernández-Sánchez J; Forero-Castro M; Matorra-Miguel M; Lumbreras E; Miguel C; Santos S; Ramírez-Maldonado V; Fuster JL; de Las Heras N; García-de Coca A; Sierra M; Dávila J; de la Fuente I; Olivier C; Olazabal J; Martínez J; Vega-García N; González T; Hernández-Rivas JM; Benito R
J Pers Med; 2020 Sep; 10(3):. PubMed ID: 32967112
[TBL] [Abstract][Full Text] [Related]
9. Detecting copy number variation in next generation sequencing data from diagnostic gene panels.
Singh AK; Olsen MF; Lavik LAS; Vold T; Drabløs F; Sjursen W
BMC Med Genomics; 2021 Aug; 14(1):214. PubMed ID: 34465341
[TBL] [Abstract][Full Text] [Related]
10. Next-Generation DNA Sequencing-Based Gene Panel for Diagnosis and Genetic Risk Stratification in Onco-Hematology.
Gargallo P; Molero M; Bilbao C; Stuckey R; Carrillo-Cruz E; Hermosín L; Pérez-López O; Jiménez-Velasco A; Soria E; Lázaro M; Carbonell P; Yáñez Y; Gómez I; Izquierdo-García M; Valero-García J; Ruiz C; Such E; Calabria I
Cancers (Basel); 2022 Apr; 14(8):. PubMed ID: 35454892
[TBL] [Abstract][Full Text] [Related]
11. A Single-Run Next-Generation Sequencing (NGS) Assay for the Simultaneous Detection of Both Gene Mutations and Large Chromosomal Abnormalities in Patients with Myelodysplastic Syndromes (MDS) and Related Myeloid Neoplasms.
Liquori A; Lesende I; Palomo L; Avetisyan G; Ibáñez M; González-Romero E; Boluda-Navarro M; Morote-Faubel M; Garcia-Ruiz C; Martinez-Valiente C; Santiago-Balsera M; Gomez-Seguí I; Sanjuan-Pla A; Sanz MA; Sanz G; Solé F; Such E; Cervera J
Cancers (Basel); 2021 Apr; 13(8):. PubMed ID: 33919541
[TBL] [Abstract][Full Text] [Related]
12. Results of next-generation sequencing gene panel diagnostics including copy-number variation analysis in 810 patients suspected of heritable thoracic aortic disorders.
Overwater E; Marsili L; Baars MJH; Baas AF; van de Beek I; Dulfer E; van Hagen JM; Hilhorst-Hofstee Y; Kempers M; Krapels IP; Menke LA; Verhagen JMA; Yeung KK; Zwijnenburg PJG; Groenink M; van Rijn P; Weiss MM; Voorhoeve E; van Tintelen JP; Houweling AC; Maugeri A
Hum Mutat; 2018 Sep; 39(9):1173-1192. PubMed ID: 29907982
[TBL] [Abstract][Full Text] [Related]
13. NGS-Based Molecular Karyotyping of Multiple Myeloma: Results from the GEM12 Clinical Trial.
Rosa-Rosa JM; Cuenca I; Medina A; Vázquez I; Sánchez-delaCruz A; Buenache N; Sánchez R; Jiménez C; Rosiñol L; Gutiérrez NC; Ruiz-Heredia Y; Barrio S; Oriol A; Martin-Ramos ML; Blanchard MJ; Ayala R; Ríos-Tamayo R; Sureda A; Hernández MT; de la Rubia J; Alkorta-Aranburu G; Agirre X; Bladé J; Mateos MV; Lahuerta JJ; San-Miguel JF; Calasanz MJ; Garcia-Sanz R; Martínez-Lopez J
Cancers (Basel); 2022 Oct; 14(20):. PubMed ID: 36291952
[TBL] [Abstract][Full Text] [Related]
14. Detection of genome-wide copy number variants in myeloid malignancies using next-generation sequencing.
Shen W; Paxton CN; Szankasi P; Longhurst M; Schumacher JA; Frizzell KA; Sorrells SM; Clayton AL; Jattani RP; Patel JL; Toydemir R; Kelley TW; Xu X
J Clin Pathol; 2018 Apr; 71(4):372-378. PubMed ID: 29197855
[TBL] [Abstract][Full Text] [Related]
15. Transforming Acute Myeloid Leukemia Treatment Through Next-Generation Sequencing: A Single-Center Experience.
Devarkonda V; Akabane H
Cureus; 2023 Sep; 15(9):e45917. PubMed ID: 37885525
[TBL] [Abstract][Full Text] [Related]
16. Next-Generation Sequencing-Based Detection of Germline Copy Number Variations in BRCA1/BRCA2: Validation of a One-Step Diagnostic Workflow.
Schmidt AY; Hansen TVO; Ahlborn LB; Jønson L; Yde CW; Nielsen FC
J Mol Diagn; 2017 Nov; 19(6):809-816. PubMed ID: 28822785
[TBL] [Abstract][Full Text] [Related]
17. Close correlation of copy number aberrations detected by next-generation sequencing with results from routine cytogenetics in acute myeloid leukemia.
Vosberg S; Herold T; Hartmann L; Neumann M; Opatz S; Metzeler KH; Schneider S; Graf A; Krebs S; Blum H; Baldus CD; Hiddemann W; Spiekermann K; Bohlander SK; Mansmann U; Greif PA
Genes Chromosomes Cancer; 2016 Jul; 55(7):553-67. PubMed ID: 27015608
[TBL] [Abstract][Full Text] [Related]
18. Clinical evaluation of panel testing by next-generation sequencing (NGS) for gene mutations in myeloid neoplasms.
Au CH; Wa A; Ho DN; Chan TL; Ma ES
Diagn Pathol; 2016 Jan; 11():11. PubMed ID: 26796102
[TBL] [Abstract][Full Text] [Related]
19. Detection of CNVs in NGS Data Using VS-CNV.
Fortier N; Rudy G; Scherer A
Methods Mol Biol; 2018; 1833():115-127. PubMed ID: 30039368
[TBL] [Abstract][Full Text] [Related]
20. Next-generation sequencing-based panel testing for myeloid neoplasms.
Kuo FC; Dong F
Curr Hematol Malig Rep; 2015 Jun; 10(2):104-11. PubMed ID: 25933675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
